Terminated PHASE1 INTERVENTIONAL 1-arm NCT02049281

A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)

A Phase I Dose Escalation Study Evaluating MK-8109 (Vintafolide) in Japanese Subjects With Advanced Solid Tumor

Sponsor: Endocyte

Interventions Vintafolide

Updated 6 times since 2017 Last updated: Feb 9, 2015 Started: Feb 28, 2014 Primary completion: May 31, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Endocyte

See all terminations from Endocyte

Other Solid Tumor trials with similar outcome

Browse all Solid Tumor trials

Listed as NCT02049281, this PHASE1 trial focuses on Solid Tumor and remains terminated or withdrawn. Sponsored by Endocyte, it has been updated 6 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE1

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Endocyte

Data source: Endocyte

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.